Awareness and Acceptance of HPV Vaccine Among Healthcare Workers of Rural Haryana: A Cross-Sectional Study
Keywords:
HPV, cervical cancer, rural healthcare workers, vaccine awareness, acceptance, CervavacAbstract
Background: Cervical cancer, primarily caused by Human Papillomavirus (HPV) infection, remains a major public health concern in India, particularly in rural regions. Despite the availability of preventive vaccines such as Cervavac, uptake among healthcare professionals—key advocates for public health—has been suboptimal. This study aims to assess the awareness, knowledge, and acceptance of HPV vaccination among healthcare workers in rural Haryana.
Methods: A cross-sectional study was conducted between January and March 2025 involving 160 healthcare professionals, including medical, nursing, and paramedical staff aged 18–45 years, from rural health centers in Haryana. Data were collected using a validated questionnaire covering demographics, HPV awareness, vaccination status, and attitudes toward vaccination. Descriptive statistics and chi-square tests were employed for analysis.
Results: The mean age of participants was 25.2 years, with a female majority (67%). While 95% of respondents were aware of the HPV vaccine and its role in preventing cervical cancer, only 16% had received vaccination. Among those aware, just 17% were vaccinated, highlighting a gap between knowledge and action. The most common barriers cited were limited availability (16%), cost concerns (5%), and lack of conviction (6%). Awareness levels were high across educational levels, but vaccination rates remained low, underscoring the need for targeted interventions.
Conclusion: Despite high awareness, HPV vaccination uptake among healthcare workers in rural Haryana is limited. Addressing practical barriers through affordable vaccine programs and strengthening advocacy among healthcare professionals is critical to enhancing HPV vaccine coverage and reducing cervical cancer burden in rural India.
Downloads
Metrics
References
World Health Organization. Human papillomavirus (HPV) and cervical cancer. 2022. Available at: https://www.who.int/news-room/fact-sheets/detail/human-papillomavirus-(hpv)-and-cervical-cancer
Mehrotra R, et al. Cervical Cancer in India: Epidemiology, Screening and Treatment. Indian J Gynecol Oncol. 2022;20(4):1-7.
Lowy DR, Schiller JT. Reducing HPV-associated cancer globally. Cancer Prev Res. 2012;5(1):18-23.
Chawla PC, et al. Knowledge, attitude and practice on human papillomavirus vaccination: A cross-sectional study among healthcare providers. Indian J Med Res. 2016;144(5):741-747.
Times Now. Cervavac launched in India: A new hope for cervical cancer prevention. Jan 2023.
WHO. HPV Vaccine Introduction Toolkit. 2021.
Kumar A, Garg P. Knowledge and practice about HPV and its vaccine among medical college students. Int J Adv Med. 2020;7:1825-1829.
Swarnapriya K, Kavitha D, Reddy GM. HPV Vaccination among medical students: A study from India. Asian Pac J Cancer Prev. 2015;16:8473–8477.
Mehta S, et al. Awareness about HPV and its vaccine among medical students in India. Indian J Community Med. 2013;38:92-94.
Tripathy S, et al. Attitudes towards HPV vaccine among healthcare workers: A cross-sectional study. Int J Reprod Contracept Obstet Gynecol. 2015;4:1771-1774.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
